Type 2 Inflammation and Its Role in Dermatologic Diseases
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.17707 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Raj Chovatiya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Prurigo, Chronic Urticaria, Urticaria. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanofi, Regeneron Pharmaceuticals.
Abstract (Originalsprache)
Atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria are immune‐mediated, inflammatory skin conditions characterized by intense itch and disease‐specific skin lesions. Despite their different clinical presentations, the three diseases are unified by an aberrant type 2 immune response involving type 2 cytokines, immune cells, and sensory nerves that may underlie their shared clinical manifestations of inflammation and pruritus. The chronic nature of these conditions is associated with significant impairment in patients' quality of life and psychological disorders, such as anxiety and depression. This article reviews type 2 inflammation and its role in atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria, focusing on the pathophysiologic drivers of type 2 inflammation in each dermatologic condition. Understanding the shared immune mechanisms that underlie these seemingly distinct skin diseases and other concomitant inflammatory conditions is critical for applying therapeutic interventions targeting the type 2 immune pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.
- Center for Medical Dermatology and Immunology Research, Chicago, Illinois, USA.
- Oregon Medical Research Center, Portland, Oregon, USA.
- Skin Cancer and Cosmetic Dermatology Center, Rome, Georgia, USA.
- Dermatologists of Central States (DOCS Dermatology), Cincinnati, Ohio, USA.
- Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
ORCID-Profile: Raj Chovatiya, Tayler Gonzalez
Förderung
- Sanofi
- Regeneron Pharmaceuticals
Zitieren
APA
Chovatiya, R., Hawkes, J. E., DiRuggiero, D., Pansch, L. A., Simcox, E., & Gonzalez, T. (2025). Type 2 Inflammation and Its Role in Dermatologic Diseases. International Journal of Dermatology. https://doi.org/10.1111/ijd.17707
Vancouver
Chovatiya R, Hawkes JE, DiRuggiero D, Pansch LA, Simcox E, Gonzalez T. Type 2 Inflammation and Its Role in Dermatologic Diseases. International Journal of Dermatology. 2025. doi:10.1111/ijd.17707
BibTeX
@article{Chovatiya2025,
author = {Chovatiya, Raj and Hawkes, Jason E and DiRuggiero, Douglas and Pansch, Leigh Ann and Simcox, Elizabeth and Gonzalez, Tayler},
title = {Type 2 Inflammation and Its Role in Dermatologic Diseases},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.17707}
}
EUVIMED